Treatment of Acute and Chronic Interstitial Nephritis with Severe Renal Impairment
Immediate Diagnostic and Therapeutic Steps
- The primary treatment for acute and chronic interstitial nephritis is immediate identification and discontinuation of any causative drug, followed by corticosteroid therapy if renal function does not improve within 3-5 days of drug cessation, as recommended by the American College of Physicians 1
- Discontinuation of the offending agent is the cornerstone of therapy, and delays in discontinuation directly correlate with poor recovery, according to the American College of Physicians 1
Exclude Other Reversible Causes
- Before initiating immunosuppression, mandatory exclusions include hypovolemia and dehydration, urinary tract obstruction, recent IV contrast exposure, urinary tract infection, and hypotension or hypertensive emergency, as recommended by the American Journal of Kidney Diseases 2, 3, and Kidney International 4
Corticosteroid Therapy Algorithm
- For Grade 3 severity, IV methylprednisolone 1-2 mg/kg daily is recommended initially, followed by transition to oral prednisone 0.5-1 mg/kg/day after clinical stabilization, as recommended by the American College of Physicians 1 and Kidney International 5
- High-dose therapy should be continued for a minimum of 4 weeks, and then tapered slowly over 6 months after achieving response, as recommended by Kidney International 4 and the American Journal of Kidney Diseases 3
Critical Prognostic Factors Affecting Recovery
- The presence of moderate fibrosis indicates a chronic component to the injury, reduced likelihood of complete recovery, and need for aggressive early intervention, as recommended by the American College of Physicians 1 and Kidney International 4
- Duration of drug exposure and delay in steroid initiation are the strongest predictors of incomplete recovery, according to the American College of Physicians 1
Management of Steroid-Resistant Disease
- If renal function fails to improve or worsens despite 4-6 weeks of corticosteroid therapy, mycophenolate mofetil (MMF) should be added, as recommended by Kidney International 4
- MMF dosing should be 1000-1500 mg twice daily, as recommended by Kidney International 4
Monitoring and Supportive Care
- Serial creatinine monitoring should be performed every 2-3 days initially, then weekly, as recommended by the American College of Physicians 1 and Praxis Medical Insights 5
- Fluid balance management and renal replacement therapy should be considered if uremic symptoms develop or volume overload becomes refractory, as recommended by the American College of Physicians 1